Cargando…

Striking reduction of amyloid plaque burden in an Alzheimer's mouse model after chronic administration of carmustine

BACKGROUND: Currently available therapies for Alzheimer's disease (AD) do not treat the underlying cause of AD. Anecdotal observations in nursing homes from multiple studies strongly suggest an inverse relationship between cancer and AD. Therefore, we reasoned that oncology drugs may be effecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayes, Crystal D, Dey, Debleena, Palavicini, Juan Pablo, Wang, Hongjie, Patkar, Kshitij A, Minond, Dimitriy, Nefzi, Adel, Lakshmana, Madepalli K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655051/ https://www.ncbi.nlm.nih.gov/pubmed/23531149 http://dx.doi.org/10.1186/1741-7015-11-81

Ejemplares similares

Chronic Cladribine Administration Increases Amyloid Beta Peptide Generation and Plaque Burden in Mice
por: Hayes, Crystal D., et al.
Publicado: (2012)

RanBP9 Plays a Critical Role in Neonatal Brain Development in Mice
por: Palavicini, Juan Pablo, et al.
Publicado: (2013)

RanBP9 Overexpression Accelerates Loss of Pre and Postsynaptic Proteins in the APΔE9 Transgenic Mouse Brain
por: Wang, Hongjie, et al.
Publicado: (2014)

Transcription Factor EB Is Selectively Reduced in the Nuclear Fractions of Alzheimer's and Amyotrophic Lateral Sclerosis Brains
por: Wang, Hongjie, et al.
Publicado: (2016)

Correction: RanBP9 Overexpression Accelerates Loss of Pre and Postsynaptic Proteins in the APΔE9 Transgenic Mouse Brain
por: Wang, Hongjie, et al.
Publicado: (2019)

SARS-CoV-2-induced autophagy dysregulation may cause neuronal dysfunction in COVID-19
por: Lakshmana, Madepalli K.
Publicado: (2021)

Carmustine-Induced Phosphatidylserine Translocation in the Erythrocyte Membrane
por: Jilani, Kashif, et al.
Publicado: (2013)

The neurotoxicity of amyloid β-protein oligomers is reversible in a primary neuron model
por: Tanokashira, Daisuke, et al.
Publicado: (2017)

TFEB Overexpression in the P301S Model of Tauopathy Mitigates Increased PHF1 Levels and Lipofuscin Puncta and Rescues Memory Deficits12
por: Wang, Hongjie, et al.
Publicado: (2016)

Novel Alzheimer risk factor IQ motif containing protein K is abundantly expressed in the brain and is markedly increased in patients with Alzheimer’s disease
por: Wang, Hongjie, et al.
Publicado: (2022)

Carmustine Wafer Implantation at the Era of Standardized Chemoradiation Protocol
por: Roux, Alexandre, et al.
Publicado: (2019)

Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors
por: Ene, Chibawanye I., et al.
Publicado: (2016)

Cerebral Infarction Related to Carmustine Wafers in Glioblastoma: A Case Report
por: Nakada, Mitsutoshi, et al.
Publicado: (2014)

Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapy
por: Kleinberg, Lawrence
Publicado: (2016)

Carmustine enhances the anticancer activity of selenite in androgen-independent prostate cancer cells
por: Thamilselvan, Vijayalakshmi, et al.
Publicado: (2012)

The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience
por: Lombardi, Giuseppe, et al.
Publicado: (2014)

To strike or not to strike? an investigation of the determinants of strike participation at the Fridays for Future climate strikes in Switzerland
por: Cologna, Viktoria, et al.
Publicado: (2021)

Enhanced anti-tumour activity of carmustine (BCNU) with tumour necrosis factor in vitro and in vivo.
por: Jones, A. L., et al.
Publicado: (1990)

Carnosic acid impedes cell growth and enhances anticancer effects of carmustine and lomustine in melanoma
por: Lin, Kun-I, et al.
Publicado: (2018)

In vitro Study of Serial Changes to Carmustine Wafers (Gliadel) with MR Imaging and Computed Tomography
por: Doishita, Satoshi, et al.
Publicado: (2017)

Adverse Event with the Use of Carmustine Wafers and Postoperative Radiochemotherapy for the Treatment of High-grade Glioma
por: Salle, Federico, et al.
Publicado: (2018)

Carmustine as a Supplementary Therapeutic Option for Glioblastoma: A Systematic Review and Meta-Analysis
por: Xiao, Zhi-Ze, et al.
Publicado: (2020)

Morphological and Calcium Signaling Alterations of Neuroglial Cells in Cerebellar Cortical Dysplasia Induced by Carmustine
por: Rodríguez-Arzate, Cynthia Alejandra, et al.
Publicado: (2021)

Carmustine Wafers Implantation in Patients With Newly Diagnosed High Grade Glioma: Is It Still an Option?
por: Ricciardi, Luca, et al.
Publicado: (2022)

Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques
por: Hashimoto, Tadafumi, et al.
Publicado: (2020)

C-terminal 37 residues of LRP promote the amyloidogenic processing of APP independent of FE65
por: Lakshmana, Madepalli K, et al.
Publicado: (2008)

Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
por: Chowdhary, Sajeel A., et al.
Publicado: (2015)

Identification of a Prognostic Microenvironment-Related Gene Signature in Glioblastoma Patients Treated with Carmustine Wafers
por: Manini, Ivana, et al.
Publicado: (2022)

First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience
por: Bock, Hans Christoph, et al.
Publicado: (2010)

NICE guidance on the use of carmustine wafers in high grade gliomas: a national study on variation in practice
por: Price, Stephen J., et al.
Publicado: (2012)

Preservation of neurocognitive function and local control of 1 to 3 brain metastases treated with surgery and carmustine wafers
por: Brem, Steven, et al.
Publicado: (2013)

The ability of hyaluronan fragments to reverse the resistance of C6 rat glioma cell line to temozolomide and carmustine
por: Karbownik, Michał Seweryn, et al.
Publicado: (2014)

Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells
por: Sukumari-Ramesh, Sangeetha, et al.
Publicado: (2015)

Double-edged Sword in the Placement of Carmustine (BCNU) Wafers along the Eloquent Area: A Case Report
por: Kuramitsu, Shunichiro, et al.
Publicado: (2014)

Symptomatic cerebral vasospasm in the setting of carmustine wafer placement for glioblastoma: A case presentation and review of literature
por: Khan, Maheen Qamar, et al.
Publicado: (2020)

Protective role of Codiaeum variegatum against genotoxicity induced by carmustine in somatic and germ cells of male mice
por: Fahmy, Maha A., et al.
Publicado: (2022)

SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism
por: Karuppan, Mohan Kumar Muthu, et al.
Publicado: (2021)

Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1
por: Yndart Arias, Adriana, et al.
Publicado: (2023)

Autophagy Modulators in Coronavirus Diseases: A Double Strike in Viral Burden and Inflammation
por: Silva, Rafael Cardoso Maciel Costa, et al.
Publicado: (2022)

Downregulation of Leucine-Rich Repeat-Containing 8A Limits Proliferation and Increases Sensitivity of Glioblastoma to Temozolomide and Carmustine
por: Rubino, Sebastian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qkqgke3n6pr2fkv242pc8sk0n7